The First Circuit vacated a lower court’s order preventing Foxconn’s subsidiary from continuing a patent arbitration in China while a related matter is being reviewed by the U.S. ITC.
In Wuhan Healthgen Biotechnology Corp. v. U.S. ITC, the Federal Circuit upheld an ITC ruling that Ventria Bioscience met the domestic industry requirement despite a modest investment in a patented bio
The Federal Circuit has upheld a PTAB decision affirming the validity of a patent for detecting genetic disorders. The ruling supports advancements in genetic diagnostics.
Hong Kong’s Inland Revenue Department outlines tax benefits for businesses under its patent box regime.
